Deep Track Capital »

Context Therapeutics shares owned by Deep Track Capital

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $15M 7.4M 2.01

More positions owned by Deep Track Capital

Amgen (AMGN)
Argenx Se Sponsored Adr (ARGX)
Axsome Therapeutics (AXSM)
Dyne Therapeutics (DYN)
Springworks Therapeutics (SWTX)
Insmed Com Par $.01 (INSM)
Guardant Health (GH)
Dynavax Technologies Corp Com New (DVAX)
Alnylam Pharmaceuticals (ALNY)
Intellia Therapeutics (NTLA)
Intra Cellular Therapies (ITCI)
Apellis Pharmaceuticals (APLS)
Ionis Pharmaceuticals (IONS)
Ocular Therapeutix (OCUL)
4d Molecular Therapeutics In (FDMT)

View all positions for Deep Track Capital

Top funds holding Context Therapeutics

Deep Track Capital
Nextech Invest
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Blue Owl Capital Holdings
Vanguard Group
Blackstone Group
Nantahala Capital Management
Franklin Resources
Alyeska Investment Group
Woodline Partners
Sio Capital Management
Affinity Asset Advisors
BlackRock
BlackRock

View all funds holding Context Therapeutics